{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:55Z","timestamp":1792686235571,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":87,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.curtheres.2022.100670","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:21:47Z","timestamp":1649103707000},"page":"100670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy and Safety Profile of Novel Oral Anticoagulants in the Treatment of Left Atrial Thrombosis: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"96","author":[{"given":"Shu-Jie","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Lan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo-Di","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.curtheres.2022.100670_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"J Eur Heart"},{"issue":"3","key":"10.1016\/j.curtheres.2022.100670_bib0002","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1160\/th15-07-0532","article-title":"Prevalence of left atrial thrombus in patients with non-valvular atrial fibrillation. A systematic review and meta-analysis of the literature","volume":"115","author":"Di Minno","year":"2016","journal-title":"Thrombosis and haemostasis"},{"key":"10.1016\/j.curtheres.2022.100670_bib0003","doi-asserted-by":"crossref","unstructured":"J.L. Blackshear, J.A. Odell. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. The Annals of thoracic surgery. 1996,61(2): 755-759. doi:10.1016\/0003-4975(95)00887-x.","DOI":"10.1016\/0003-4975(95)00887-X"},{"key":"10.1016\/j.curtheres.2022.100670_bib0004","doi-asserted-by":"crossref","unstructured":"N.C. Wang, M.D. Sather, A. Hussain, et al. Oral anticoagulation and left atrial thrombi resolution in nonrheumatic atrial fibrillation or flutter: A systematic review and meta-analysis. Pacing and clinical electrophysiology: PACE. 2018,41(7): 767-774. doi:10.1111\/pace.13368.","DOI":"10.1111\/pace.13368"},{"key":"10.1016\/j.curtheres.2022.100670_bib0005","doi-asserted-by":"crossref","unstructured":"C. Hammerstingl, B. P\u00f6tzsch, G. Nickenig, Resolution of giant left atrial appendage thrombus with rivaroxaban. Thrombosis and haemostasis. 2013, 109(4): 583-4. doi:10.1160\/th12-11-0821.","DOI":"10.1160\/TH12-11-0821"},{"issue":"6","key":"10.1016\/j.curtheres.2022.100670_bib0006","first-page":"1087","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis\u2013Task Force on Anticoagulants in Heart Disease","volume":"110","author":"De Caterina","year":"2013","journal-title":"Thrombosis and haemostasis"},{"key":"10.1016\/j.curtheres.2022.100670_bib0007","doi-asserted-by":"crossref","unstructured":"P. Bernhardt, H. Schmidt, C. Hammerstingl, et al. Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging. The American journal of cardiology. 2004, 94(6): 801-4. doi:10.1016\/j.amjcard.2004.06.010","DOI":"10.1016\/j.amjcard.2004.06.010"},{"key":"10.1016\/j.curtheres.2022.100670_bib0008","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"British Medical Journal (Clinical research ed.)"},{"key":"10.1016\/j.curtheres.2022.100670_bib0009","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"British Medical Journal (Clinical research ed.)"},{"key":"10.1016\/j.curtheres.2022.100670_bib0010","unstructured":"Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: URL: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm [cited 2021 July 19]"},{"key":"10.1016\/j.curtheres.2022.100670_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijcard.2015.04.104","article-title":"Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation","volume":"190","author":"Hao","year":"2015","journal-title":"International journal of cardiology"},{"key":"10.1016\/j.curtheres.2022.100670_bib0012","doi-asserted-by":"crossref","unstructured":"A. Hussain, W.E. Katz, M.V. Genuardi, et al. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter. Pacing and clinical electrophysiology: PACE. 2019, 42(9): 1183-1190. doi:10.1111\/pace.13765.","DOI":"10.1111\/pace.13765"},{"issue":"2","key":"10.1016\/j.curtheres.2022.100670_bib0013","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11239-019-01876-z","article-title":"Efficacy and safety of rivaroxaban on the resolution of left atrial\/left atrial appendage thrombus in nonvalvular atrial fibrillation patients","volume":"48","author":"Ke","year":"2019","journal-title":"Journal of thrombosis and thrombolysis"},{"issue":"1","key":"10.1016\/j.curtheres.2022.100670_bib0014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00392-020-01651-8","article-title":"Clinical outcomes and thrombus resolution in patients with solid left atrial appendage thrombi: results of a single-center real-world registry","volume":"110","author":"Nelles","year":"2021","journal-title":"Clinical research in cardiology: official journal of the German Cardiac Society"},{"issue":"3","key":"10.1016\/j.curtheres.2022.100670_bib0015","first-page":"208","article-title":"Clinical analysis of non-vitamin K antagonist oral anticoagulants in treatment of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation","volume":"23","author":"Mei","year":"2019","journal-title":"Chinese Journal of Cardiac Arrhythmias"},{"issue":"6","key":"10.1016\/j.curtheres.2022.100670_bib0016","first-page":"461","article-title":"Clinical characteristics and prognosis of the patients with nonvalvular atrial fibrillation combining left atrial thrombosis and the efficacy of the anticoagulant drugs","volume":"22","author":"Lirong","year":"2018","journal-title":"Chin J Cardiac Arrhyth"},{"issue":"12","key":"10.1016\/j.curtheres.2022.100670_bib0017","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"10","key":"10.1016\/j.curtheres.2022.100670_bib0018","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"The New England journal of medicine"},{"issue":"11","key":"10.1016\/j.curtheres.2022.100670_bib0019","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"The New England journal of medicine"},{"key":"10.1016\/j.curtheres.2022.100670_bib0020","doi-asserted-by":"crossref","unstructured":"R.P. Giugliano, C.T. Ruff, E. Braunwald, et al. Edoxaban versus warfarin in patients with atrial fibrillation. The New England journal of medicine. 2013,369(22): 2093-104. doi:10.1056\/NEJMoa1310907.","DOI":"10.1056\/NEJMoa1310907"},{"issue":"5","key":"10.1016\/j.curtheres.2022.100670_bib0021","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.amjcard.2014.12.016","article-title":"Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutter","volume":"115","author":"Zylla","year":"2015","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.curtheres.2022.100670_bib0022","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/jce.14502","article-title":"Warfarin vs non-vitamin K oral anticoagulants for left atrial appendage thrombus: A meta-analysis","volume":"31","author":"Murtaza","year":"2020","journal-title":"Journal of cardiovascular electrophysiology"},{"issue":"6","key":"10.1016\/j.curtheres.2022.100670_bib0023","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/07853890.2018.1495337","article-title":"Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)","volume":"50","author":"Miyazawa","year":"2018","journal-title":"Annals of medicine"},{"key":"10.1016\/j.curtheres.2022.100670_bib0024","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip","year":"2016","journal-title":"American Heart Journal"},{"key":"10.1016\/j.curtheres.2022.100670_bib0025","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/jce.14568","article-title":"Letter to the editor: Meta-analyses for oral anticoagulants and left atrial appendage thrombus resolution in nonvalvular atrial fibrillation: Piecing the puzzle together","volume":"31","author":"Hussain","year":"2020","journal-title":"Journal of cardiovascular electrophysiology"},{"issue":"4","key":"10.1016\/j.curtheres.2022.100670_bib0026","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mhj.2003.91","article-title":"Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation","volume":"145","author":"Stoddard","year":"2003","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.curtheres.2022.100670_bib0027","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11239-016-1421-9","article-title":"Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal","volume":"43","author":"Marsico","year":"2016","journal-title":"Journal of thrombosis and thrombolysis"},{"issue":"9921","key":"10.1016\/j.curtheres.2022.100670_bib0028","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.curtheres.2022.100670_bib0029","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.thromres.2014.05.035","article-title":"Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients","volume":"13","author":"Mearns","year":"2014","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.curtheres.2022.100670_bib0030","doi-asserted-by":"crossref","first-page":"e42269","DOI":"10.1371\/journal.pone.0042269","article-title":"Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis","volume":"7","author":"Erkens","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.curtheres.2022.100670_bib0031","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.curtheres.2022.100670_bib0032","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH11-05-0353","article-title":"Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients","volume":"106","author":"Gallagher","year":"2011","journal-title":"Thrombosis and haemostasis"},{"issue":"3","key":"10.1016\/j.curtheres.2022.100670_bib0033","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jacep.2016.01.004","article-title":"Prevalence of Left Atrial Thrombus Detection by Transesophageal Echocardiography: A Comparison of Continuous Non-Vitamin K Antagonist Oral Anticoagulant Versus Warfarin Therapy in Patients Undergoing Catheter Ablation for Atrial Fibrillation","volume":"2","author":"Frenkel","year":"2016","journal-title":"JACC. Clinical electrophysiology."},{"issue":"8","key":"10.1016\/j.curtheres.2022.100670_bib0034","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1540-8167.2010.01729.x","article-title":"Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation","volume":"21","author":"Wallace","year":"2010","journal-title":"Journal of cardiovascular electrophysiology"},{"issue":"9","key":"10.1016\/j.curtheres.2022.100670_bib0035","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(02)01785-0","article-title":"Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study","volume":"39","author":"Seidl","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1016\/j.curtheres.2022.100670_bib0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1540-8167.2008.01336.x","article-title":"Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation","volume":"20","author":"Scherr","year":"2009","journal-title":"Journal of cardiovascular electrophysiology"},{"issue":"2","key":"10.1016\/j.curtheres.2022.100670_bib0037","first-page":"289","article-title":"RIVAroxaban TWICE daily for lysis of thrombus in the left atrial appendage in patients with non-valvular atrial fibrillation: the RIVA-TWICE study. Archives of medical science","volume":"16","author":"Piotrowski","year":"2020","journal-title":"AMS"},{"issue":"26","key":"10.1016\/j.curtheres.2022.100670_bib0038","doi-asserted-by":"crossref","first-page":"e11117","DOI":"10.1097\/MD.0000000000011117","article-title":"Anticoagulation efficacy of dabigatran etexilate for left atrial appendage thrombus in patients with atrial fibrillation by transthoracic and transesophageal echocardiography","volume":"97","author":"Xing","year":"2018","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.curtheres.2022.100670_bib0039","first-page":"606","article-title":"Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation","volume":"46","author":"Cui","year":"2018","journal-title":"Zhonghua xin xue guan bing za zhi"},{"issue":"3","key":"10.1016\/j.curtheres.2022.100670_bib0040","first-page":"174","article-title":"Apixaban successfully resolved a warfarin-resistant left atrial appendage thrombus in a patient with end-stage renal disease on hemodialysis","volume":"21","author":"Park","year":"2019","journal-title":"Anatolian journal of cardiology"},{"issue":"10","key":"10.1016\/j.curtheres.2022.100670_bib0041","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.drudis.2017.05.010","article-title":"Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation","volume":"22","author":"Orenes-Pi\u00f1ero","year":"2017","journal-title":"Drug discovery today"},{"issue":"2","key":"10.1016\/j.curtheres.2022.100670_bib0042","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10840-018-0432-1","article-title":"Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution","volume":"53","author":"Wu","year":"2018","journal-title":"Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing"},{"key":"10.1016\/j.curtheres.2022.100670_bib0043","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ahj.2017.07.016","article-title":"Comparison of prevalence and management of left atrial appendage thrombi under old and new anticoagulants prior to left atrial catheter ablation","volume":"193","author":"Da Costa","year":"2017","journal-title":"American Heart Journal"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X22000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X22000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:59:02Z","timestamp":1757897942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X22000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":43,"alternative-id":["S0011393X22000091"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2022.100670","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety Profile of Novel Oral Anticoagulants in the Treatment of Left Atrial Thrombosis: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2022.100670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100670"}}